Literature DB >> 23656242

Donor-specific tolerance induction in organ transplantation via mixed splenocytes chimerism.

S Yamazaki1, A Kanamoto, T Takayama.   

Abstract

We have shown previously that donor-derived splenocytes can replace recipients' bone marrow and induce donor-specific tolerance (DST). We have also shown the usefulness of the chimeric state for the induction of DST. Further analysis of mixed splenocytes chimera, especially the role of each T cells in mixed splenocytes chimera, is indispensable issue for its clinical use. A chimeric state has been shown to achieve long-term survival in major histocompatibility complex (MHC)-mismatched grafts. The donor-derived splenocytes can replace recipients' bone marrow and induce DST. The long-term survival of allogeneic skin grafts was achieved without immunosuppressants. In this study we show the role of each T cell type in a splenocyte mixed chimera. This review provides a short summary of our original work, adding some supplemental interpretations. Mixed chimerism is thus considered an attractive approach for the induction of DST without the use of immunosuppressants. In this paper, we summarize some of the findings on mixed splenocyte chimeras and review mixed chimerism in recent organ transplantation.
© 2013 British Society for Immunology.

Entities:  

Keywords:  bone marrow; chimerism; donor-specific tolerance; skin graft; splenocyte

Mesh:

Substances:

Year:  2013        PMID: 23656242      PMCID: PMC3722917          DOI: 10.1111/cei.12131

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates.

Authors:  Tatsuo Kawai; Hiroshi Sogawa; Svetlan Boskovic; Gregory Abrahamian; Rex-Neal Smith; Siew-Lin Wee; David Andrews; Ognjenka Nadazdin; Ichiro Koyama; Megan Sykes; Henry J Winn; Robert B Colvin; David H Sachs; A Benedict Cosimi
Journal:  Am J Transplant       Date:  2004-09       Impact factor: 8.086

2.  Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver.

Authors:  N Kashiwagi; K A Porter; I Penn; L Brettschneider; T E Starzl
Journal:  Surg Forum       Date:  1969

Review 3.  Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance.

Authors:  S Sakaguchi; N Sakaguchi; J Shimizu; S Yamazaki; T Sakihama; M Itoh; Y Kuniyasu; T Nomura; M Toda; T Takahashi
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

4.  Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance.

Authors:  T Kawai; A Poncelet; D H Sachs; S Mauiyyedi; S Boskovic; S L Wee; D S Ko; A Bartholomew; M Kimikawa; H Z Hong; G Abrahamian; R B Colvin; A B Cosimi
Journal:  Transplantation       Date:  1999-12-15       Impact factor: 4.939

5.  Active role of chimerism in transplantation tolerance induced by antilymphocyte serum, sirolimus, and bone-marrow-cell infusion.

Authors:  Akira Kanamoto; Anthony P Monaco; Takashi Maki
Journal:  Transplantation       Date:  2004-09-27       Impact factor: 4.939

6.  Long-term effects of cyclosporine on renal function in liver transplant recipients.

Authors:  H C Wheatley; M Datzman; J W Williams; D E Miles; F E Hatch
Journal:  Transplantation       Date:  1987-05       Impact factor: 4.939

7.  Chimeric donor cells play an active role in both induction and maintenance phases of transplantation tolerance induced by mixed chimerism.

Authors:  Akira Kanamoto; Takashi Maki
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

8.  Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients.

Authors:  W H Barber; J A Mankin; D A Laskow; M H Deierhoi; B A Julian; J J Curtis; A G Diethelm
Journal:  Transplantation       Date:  1991-01       Impact factor: 4.939

9.  Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.

Authors:  S T Ildstad; S M Wren; E Oh; M L Hronakes
Journal:  Transplantation       Date:  1991-06       Impact factor: 4.939

10.  Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen.

Authors:  Y Sharabi; D H Sachs
Journal:  J Exp Med       Date:  1989-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.